Vienna13 Capital (@Vienna13Capital) header
Vienna13 Capital (@Vienna13Capital) profile picture

portfolio manager at a familiy office

Joined May 2022
Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)Photo by Vienna13 Capital (@Vienna13Capital)
just seen that @orrdavid made openhouse $3288 a top 10 position in $ORR . always a good hunting ground for ideas (especially if they overlap with my positions :) ) open house has compounded tremendously for a long time, has very sharp management (met them in Tokyo) and a niche with long runway despite demographics. trades currently at the lower end of their valuation range. has morphed into a low beta, low yen exposure stock (see charts) like this one a lot.
3
5
57
5,108
Vienna13 Capital retweeted
$HAYPP Q3 takeaway: Another strong quarter, in my view. A modest beat to my expectations, with the US and UK looking exceptionally healthy. After all, most of Haypp's future value likely lies in these markets. Perhaps another case of Swedes selling and US investors buying a few hours later. Though Nasdaq being down 6% might mask the real reaction.
Haypp Group announces Q3 2026 results, with net sales up 28%, gross profit up 35% w/ nicotine pouch volume growth over 90% in US & UK Report storage.mfn.se/5cde23a6-d889… Presentation storage.mfn.se/a/haypp/36293… $HAYPP
4
18
1,492
I was obviously bullish on helios towers $HTWS when I did my write up in March 2025. helios has played out nicely so far. what surprised me though (positively) is that helios worked well, while the overall sector sucked since then. helios has outperformed all the major peers since its listing in 2019 and also since the write-up in march 2025 (see charts below) solid earnings results again today from helios, long runway ahead and a very well executing and consistent management team
1
8
316
Vienna13 Capital retweeted
Did uneducated guesses on P when unavailable. Over the last 6Y Patria 'acquired' FEAUM at an average P of 2.85%. Patria (after being down 40% YTD) trades at 3.25%. Moreover, the deals did really improve the business (diversification into GPMS, RE and Credit and outside Brazil)
1
1
2
206
finally some quality $Sofw research 🤣
Two SUPERB devices walk into a clinic. The physician says, “You two look a little worked up.” One replies, “You should check our pulse.” “Why, is it racing?” “About 60% faster than last year. Is that normal?"
3
340
Vienna13 Capital retweeted
Written for those who are not experts on the S-1: how the economics work, where the risks sit, what surprised me, some questions, and what it means for us who use these tools. I know the world does not need another S-1 take, read the disclosure first.
11
5
2
25
6,959
Schneider Electric $SU.FP justification for PTC m/a "ROCE>WACC by year 5" is one of the worst I've seen in an otherwise outstanding business. I wouldn't be surprised if the CEO is out in 2 years due to this aquisition
1
11
1,377
👀
Welcome to China, Sofwave Medical! 🎉 "pleased to announce that on September 24, 2026, HTDK notified the Company that it has received the approval of the National Medical Products Administration of China (NMPA)(1) to market the Sofwave(TM) system in mainland China". Here we go! $SOFW $SOFW.TA (TAM just doubled). Holding. Not a rec. DYODD.
3
497
given my experience with $par that sounds about right
The ARR multiple fallacy ARR multiple is not the right way to think about sub-20% growers. Simple framework: If you’re growing sub-20%, you get a 10-30x EBIDTA or FCF multiple. If you use this rubric, Miro is very fairly valued by Bending Spoons. Only 30%+ growers get the luxury of an ARR multiple. The reason is that 30% growth means you’re doubling in 3 years and so the revenue base will be 2x in 36 months, and the margin structure will look different at 2x scale. Cash flow today is a rounding error against that. So you value the trajectory, and ARR is the cleanest proxy for trajectory. At 15% growth, doubling takes 5 years. That's close enough to "never" that the market stops paying for the future and starts paying for the present. The present is earnings. If you're not producing them, you're not a growth company anymore. You're a bad value company. The mistake founders make is anchoring to the multiple they had at 40% growth and thinking the ARR multiple just compresses. It doesn't compress. It gets replaced. You cross 30% on the way down and the entire valuation framework switches out from under you. Which is why the worst place to be is 20-30% growth with no FCF. Growth investors won't pay for it. Value investors can't. You're priced by whoever is least excited,a really painful place to be.
2
1
4
1,218
Vienna13 Capital retweeted
We’re sharing a solution to the Navier-Stokes Millennium Prize Problem, one of the deepest problems at the frontier of mathematics. The proof was produced by a group of agents, using an OpenAI next-generation model significantly more capable than GPT-6 Astra. The problem concerns whether the description of smooth three-dimensional fluid motion modeled by the Navier-Stokes equations can break down. It has remained unresolved for roughly 90 years.
5,639
19,976
14,813
119,704
75,447,279
Vienna13 Capital retweeted
$SOFW SOFWAVE MEDICAL Just released Q2 numbers. Market initially probably didn't like "rev deceleration" sequentially from 46% in Q1 vs. 43% in Q2. I don't really care, that seems to be noise in an intact growth and op leverage story. System vs. pulse sales looks fine. Bottom-line looks a bit off but seems mainly from Nasdaq listing expenses (truly one-time, unlike SBC). Seems all intact to me. Depending on view, I think for FY26 that trades roughly on 30 x EBIT. Don't think that's expensive for something growing 40%+ while inflecting on profitability. If growth runway continues to expand, share price will take care of itself. Disclosure: I'm long.
1
1
19
1,739
picking on sell-side is too easy sometimes😂 young JP Morgan analyst comes in with initiation on $PAR with PT 20% below the stock price only to revise it upward to 10% above stock price a week later because she has the share count wrong in her model (she calls the revision "update in methodology" instead of erratum)🤦‍♂️ disclaimer: I should be careful since I was obviously wrong on the stock. but at least I don't mess up the objective facts like number of shares
2
16
3,954
Vienna13 Capital retweeted
Great summary of our recent Sofwave site visit by @roncohen0547
לפני שבוע @pbcinc (👑) הציע לי להצטרף אליו לשיחה במשרדים של $SOFW שם דיברנו עם ד"ר שמעון אקהאוס המייסד ואסף מנצור ה CFO. גם ד"ר שמעון וגם אסף אנשים מוכשרים מאוד, חכמים מאוד אבל גם צנועים מאוד שממוקדים בדבר אחד - להביא את החברה קדימה ולהיות החברה הטובה ביותר בתחום, ובאמת אחרי השיחה איתם אין לי ספק שהם בדרך הנכונה לשם. הנה סיכום של כמה נקודות חשובות שהיו בשיחה: 1/6 לא המלצה, מחזיק ובשמחה רבה.
1
3
19
3,057
ok, this one worked well. $HTWS up ~120% since my write-up last March. nice if something works as planned (or better to be honest)
I organized my thoughts about $HTWS in a write-up. Thought I try something new and share it. Link in the comment below or via profile @Vienna13Capital . TLDR version: $HTWS is a predictable, durable and growing cash flow stream generated by mission critical infrastructure trading at a 50% discount to European peers and a 66% discount to US peers, despite higher anticipated revenue growth, lower leverage and equal tenancy ratios. While there is plenty of re-rating potential, the stock can credibly deliver double digit (even > 20%) IRRs without any re-rating. Management communication about the initiation and details of shareholder distributions act as a near term catalyst.
3
9
720
Vienna13 Capital retweeted
Hi - I didn’t sell any shares. This is for taxes, which happens automatically. I would never sell a share of a company that I have influence on. And yes, I would absolutely put my money where our mouth is as soon as I’m able to. Feel free to ping me directly.
2
1
9
674
Vienna13 Capital retweeted
1/ FULL Post-mortem – Why I sold $SLYG After seeing your responses, receiving many questions, and reading some very well-done threads — some challenging my points — I decided to write up my main reason for selling Shelly. I also decided to respond to @ThomasTangMI 's thread. Selling was not hard. What has been extremely difficult is letting the story go, after it being a core position of Arauca for so long. I think the best thing for me is to write in full what I saw in the annual report and public filings and what my rationale was. An important disclaimer: there is only one point in this post-mortem that I did not know when I sold. I decided to add it anyway, as it raises an important set of questions. I learned it through @mavix_leon 's latest thread, and it relates to what was behind the BGN receivables, an aspect I was extremely curious about but did not know before. Mavix also subsequently reached out to me privately to clarify certain points from his thread — I have incorporated both his public thread and his private clarification in Tweet 3, with full attribution and with the appropriate caveats. So, when you see me discussing that specifically, you should know I only learned it a few days ago. I knew about receivables booked in BGN of course — but not what was behind them. Everything else comes from the official reports — so nothing I post should be a surprise. It is all there. What I am sharing is how I read that information, and that is my entirely personal interpretation. As I said previously, I am not responding to the company's FAQ. I have moved on. I do however raise many questions in this post-mortem — but those are exclusively my honest questions. I have shared all of these points privately with some of you and have seen a range of interpretations, which has been a wonderful exchange. I decided to share it with everyone. You might ask, given some negative reactions, why I do it. Well — first, I learned how to use the block button. Second, I do it more for myself, to put an end to the story and express clearly, while it is still fresh, my exact thought process. Additionally, nothing that follows should be new to you: I have already sold, everything comes from the financial statements except the BGN receivables detail from Mavix, and I have incorporated some of the most frequent questions I have received — so this also serves as a final reference document. In this post-mortem I cover mostly reason number one: the lack of cash flow generation and the increase in receivables and why that is a problem for me. Almost all points relate to that. That is the bulk of why I exited Shelly. I am not covering every reason — mostly reason number one. One more thing before we start. I received a lot of pushbacks on my comments about the optics of the compensation package. I stand by them entirely, and I have dedicated a full section to explaining exactly why — including how the package actually worked, because I think most of the criticism came from a misunderstanding of its mechanics. I will get to that in Tweet 6. One clarification upfront, because it is the most common misreading of my position. My concern is not that Shelly burns cash — high-growth companies burn cash and I accept that completely. I would have been comfortable with negative free cash flow if the cash were going into R&D, marketing, capex, or inventory. Those are investments you can evaluate. What makes Shelly different is that the cash is not going there. It is sitting in receivables. That distinction is the entire foundation of my decision. One important point: my reasons for selling and my concerns are in many ways easy for the company to fix and demonstrate. Nothing more is needed than meaningful cash flow generation and a reduction in receivables over the course of the year. I am equally sure that this will be a catalyst for improved communication. I have said repeatedly that I am a Shelly fan — of the products and of what the company has built. That cannot be taken away. But I am truly disappointed by the lack of cash flow and the working capital metrics and the facts for the investment definitely changed. Important Disclosure: Neither Arauca Capital nor I, nor any closely related person, nor any firm that does business with me or my firms, has any position — short or long — in Shelly shares, to my knowledge. This post is therefore entirely informational. My intention is to show you how I came to this conclusion. For reference, my position in Shelly was long-only for years. I never trimmed. I sold the full position following the Q4 2025 results, and that is that. Please note that nothing in this thread can be considered investment advice, and this is not an investment recommendation. The thread is long and may contain mistakes — if so, they are mine. Please verify everything independently and do not take anything I say below as fact. I hope to share my process, why I sold, and the questions that continue to dominate my thinking.
3
10
1
41
13,942
$VNA Vonovia -10% on decent earnings. seems a bit overdone. I know probably it is anticipation of higher rates due to current events in ME, but given they plan further asset sales and debt reduction it still seems like an attractive valuation. thoughts @askjussi ?
3
8
1,583
claims he and then disables comments… anyway I just commented in the first place because I was surprised about the hostility in the otherwise sharp and nice bubble of shelly investors/observers. usually if you have conviction you‘d just buy more stock when it drops instead of ranting about the sellers. anyways have a nice evening @sergimp16
Replying to @Vienna13Capital
he has never seen the ar, so I doubt he can judge if they are legit or not
5
948